Next Article in Journal / Special Issue
Pharmacology and Adverse Events of Emergency-Use Authorized Medication in Moderate to Severe COVID-19
Previous Article in Journal
The Novel Application of Geometric Morphometrics with Principal Component Analysis to Existing G Protein-Coupled Receptor (GPCR) Structures
Previous Article in Special Issue
Neuropsychiatric Disorders and COVID-19: What We Know So Far
 
 
Article

Article Versions Notes

Pharmaceuticals 2021, 14(10), 954; https://doi.org/10.3390/ph14100954
Action Date Notes Link
article pdf uploaded. 23 September 2021 16:01 CEST Version of Record https://www.mdpi.com/1424-8247/14/10/954/pdf-vor
article supplementary file uploaded. 23 September 2021 16:01 CEST - https://www.mdpi.com/1424-8247/14/10/954#supplementary
article xml file uploaded 24 September 2021 10:11 CEST Original file -
article xml uploaded. 24 September 2021 10:11 CEST Update https://www.mdpi.com/1424-8247/14/10/954/xml
article pdf uploaded. 24 September 2021 10:11 CEST Updated version of record https://www.mdpi.com/1424-8247/14/10/954/pdf-vor
article html file updated 24 September 2021 10:17 CEST Original file -
article html file updated 25 September 2021 10:00 CEST Update -
article pdf uploaded. 21 October 2021 11:19 CEST Updated version of record https://www.mdpi.com/1424-8247/14/10/954/pdf-vor
article html file updated 21 October 2021 11:27 CEST Update -
article pdf uploaded. 22 October 2021 09:07 CEST Updated version of record https://www.mdpi.com/1424-8247/14/10/954/pdf-vor
article pdf uploaded. 22 October 2021 09:08 CEST Updated version of record https://www.mdpi.com/1424-8247/14/10/954/pdf
article html file updated 22 October 2021 09:08 CEST Update -
article html file updated 22 October 2021 09:09 CEST Update -
article html file updated 30 July 2022 07:16 CEST Update https://www.mdpi.com/1424-8247/14/10/954/html
Back to TopTop